Stock listing
AEON Stock Price, News, Filings & Events — Aeon Biopharma, Inc.
Selected listing: AEON · BOATS · USD · US
This page tracks Aeon Biopharma, Inc.'s AEON:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AEON:BOATS. AEON:BOATS is the stock-level entry point for investors researching Aeon Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aeon Biopharma, Inc. is a public company traded under the ticker AEON in the American market. The company has a market capitalization of approximately $11 million. Aeon Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
- Ticker
- AEON:BOATS
- Asset type
- Stock
- Market cap
- $16.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Aeon Biopharma, Inc. AEON:BOATS stock context
This page tracks Aeon Biopharma, Inc.'s AEON:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AEON:BOATS. AEON:BOATS is the stock-level entry point for investors researching Aeon Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aeon Biopharma, Inc. is a public company traded under the ticker AEON in the American market. The company has a market capitalization of approximately $11 million. Aeon Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
Latest news from Aeon Biopharma, Inc.
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
August 3, 2026
AEON Biopharma : Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for...
July 14, 2026
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for A...
July 14, 2026
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific M...
June 4, 2026
Research Aeon Biopharma, Inc.
Aeon Biopharma, Inc. investor report
Review AI stock analysis and investor report context for AEON:BOATS.
Aeon Biopharma, Inc. company profile
View the public company page for Aeon Biopharma, Inc. on 6ix.
Aeon Biopharma, Inc. news
Read company news and market updates connected to Aeon Biopharma, Inc..
Aeon Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Aeon Biopharma, Inc..